Compound 714
Identifiers
- Canonical SMILES:
CCN1CCN(CC[C@H](CSc2ccccc2)Nc2ccc(cc2S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc2ncnc3CN(CCc23)C2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)CC1
- InChi:
InChI=1S/C48H56ClF3N8O4S3/c1-2-57-26-28-58(29-27-57)22-18-38(33-65-40-9-4-3-5-10-40)55-44-17-16-41(30-46(44)66(61,62)48(50,51)52)67(63,64)56-47-43-21-25-60(32-45(43)53-34-54-47)39-19-23-59(24-20-39)31-36-8-6-7-11-42(36)35-12-14-37(49)15-13-35/h3-17,30,34,38-39,55H,2,18-29,31-33H2,1H3,(H,53,54,56)/t38-/m1/s1
- InChiKey:
PKUWTSLEHNOKOL-KXQOOQHDSA-N
External links
88540245 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 23 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.29 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 996.32 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.84 | |||
TPSA | 131.08 | |||
RB | 17 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 23 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.29 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5128 | Navitoclax | DB12340 | |
0.4146 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3854 | GDC-0349 | DB13072 | |
0.3846 | Sulfaisodimidine | DB13283 | |
0.3780 | Presatovir | DB12165 | |
0.3776 | Quinupristin | DB01369 | |
0.3729 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3718 | Sparsentan | DB12548 | |
0.3655 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3591 | PF-03814735 | DB13059 | |
0.3587 | Dubermatinib | DB15187 | |
0.3549 | Nelivaptan | DB12643 | |
0.3547 | Elobixibat | DB12486 | |
0.3529 | Anatibant | DB05038 | |
0.3529 | Bleomycin | DB00290 |